Glenmark concludes PMS study on favipiravir in over 1000 COVID-19 patients
Results showed no new safety signals or concerns with the use of favipiravir, and already-known side effects such as weakness, gastritis, diarrhea, vomiting, etc., were found to be mild in nature. The time for fever resolution was 4 days, while the time for a clinical cure was 7 days.